Autres langues Applied BioCode Corporation

Actions

6598

KYG0488D1051

Cours en clôture Taiwan S.E. Autres places de cotation 00:00:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
19,75 ^TWD	0,00 %		+0,77 %	-21,94 %

15/04	Applied BioCode annonce le lancement de l'essai STI + Resistance Panel à usage exclusif de la recherche	CI
21/03	Applied BioCode annonce des changements de PDG	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	15/04
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	15/04
Applied BioCode Announces Retirement of CEO Chris Bernard	21/03
Applied BioCode Announces CEO Changes	21/03
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer	28/09/23
Applied BioCode Appoints Beth Laderman as Chief Scientific Officer	28/09/23
Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer	23/09/23
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/08/23
Applied BioCode Corporation Announces the Change of Representative of Institutional Director	14/06/23
Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use	12/06/23
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use	12/06/23
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Applied BioCode Announces Distribution Agreement with Medline Industries	08/05/23
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries	08/05/23
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22/03/23
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22/03/23
Applied BioCode Corporation Appoints Liang-Kai Huang as Corporate Governance Officer	13/03/23
Applied BioCode Announces 2022 Q4 and Full year Revenue	27/02/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Applied BioCode Corporation

Actions

6598

KYG0488D1051

Autres langues

Filtres